Serum Institute of India acquires 20% stake in IntegriMedical
The largest vaccine manufacturer in the world, Serum
Institute of India (SII), purchased a 20% share in IntegriMedical, a US-based
company, in order to further the development of needle-free injection system
technology.
The deal’s financial specifics were kept under wraps.
In a statement released on Friday, Pune-based SII said that
the collaboration with IntegriMedical is in line with both company’s goals of
“Health for All” and “Transforming Healthcare Globally” through the provision
of patient comfort, assurance of improved patient compliance, a decrease in
needle-stick injuries, and an improvement in the effectiveness of liquid
medication through needle-free dispersion.
Read more@ https://www.indiainfoline.com/news/companies/serum-institute-acquires-20-stake-in-integrimedical
Comments
Post a Comment